JPM News Alert JP Morgan Chase & Co (JPM) 58.98 01/06/2015 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
JP Morgan Chase & Co (JPM) 58.98 $JPM

Morgan Stanley Reveals Data Breach by Employee, Probe On - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 53 mins ago
Morgan Stanley disclosed that information regarding nearly 10% or 350,000 of its wealth management clients was stolen by one of its employees, with some of it even posted online.
HD: 100.95 (-0.31), JPM: 58.98 (-1.57), TGT: 73.97 (-0.01), MIK: 23.91 (+0.18), MS: 36.42 (-1.08)

Most active New York Stock Exchange-traded stocks
AP - 54 mins ago
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
TLM.TO: 9.11 (+0.04), KO: 42.46 (+0.32), GE: 24.07 (-0.53), F: 14.62 (-0.14), JPM: 58.98 (-1.57), TLM: 7.71 (-0.03), S: 4.19 (-0.02), PFE: 31.42 (+0.26), C: 50.70 (-1.85), BAC: 16.86 (-0.52), TWTR: 38.76 (+2.38), RAD: 7.71 (+0.19)

Universal Corporation Completes New Credit Facility Agreement
PR Newswire - 1 hr 9 mins ago
Universal Corporation (NYSE: UVV) disclosed in a filing with the Securities and Exchange Commission on December 31, 2014, that the Company has executed a new bank credit facility agreement which consolidates and extends maturities of its short-term revolving credit and long-term borrowing facilities. J.P. Morgan Securities LLC, SunTrust Robinson Humphrey, Inc., and AgFirst Farm Credit Bank led the transaction. The new agreement includes a $430 million 5-year revolving credit facility, a $150 million 5-year term loan, and a $220 million 7-year term loan. The revolving credit facility contains terms and conditions that are substantially similar to the Company's previous revolving credit facility. The term loans, which were fully funded at closing, require no amortization and are prepayable without penalty prior to maturity. The facilities include a customary accordion feature allowing for additional borrowings of up to $100 million under certain conditions. Currently, borrowings under the agreement bear interest at variable rates based on LIBOR plus a margin of 1.50% to 1.75%.
JPM: 58.98 (-1.57), UVV: 40.46 (+0.08)

SunTrust Q4 Results to Include New $145M Legal Reserve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 18 mins ago
SunTrust's fourth-quarter 2014 results will include a new legal provision expense of $145 million, thereby lowering its earnings by 17 cents per share.
JPM: 58.98 (-1.57), C: 50.70 (-1.85), STI: 39.08 (-1.16), BAC: 16.86 (-0.52)

JPMorgan Chase Set to Possibly Rebound After Yesterday's Selloff of 2.59%
Comtex SmarTrend(R) - 2 hrs 18 mins ago
JPMorgan Chase (NYSE:JPM) traded in a range yesterday that spanned from a low of $58.35 to a high of $60.75. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $60.23 on volume of 29.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JPM: 58.98 (-1.57)

After Yesterday's Decline of 2.59%, JPMorgan Chase Offers Investors Better Value
Comtex SmarTrend(R) - 2 hrs 18 mins ago
JPMorgan Chase (NYSE:JPM) traded in a range yesterday that spanned from a low of $58.35 to a high of $60.75. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $60.23 on volume of 29.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JPM: 58.98 (-1.57)

Owens & Minor to Participate in 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015
Business Wire - 2 hrs 28 mins ago
Owens & Minor, Inc. (NYSE:OMI) will participate in the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2015, at 10:30 a.m. Pacific Time. The Owens & Minor presentation will be webcast live and later archived at www.owens-minor.com under the Investor Relations section.
JPM: 58.98 (-1.57), OMI: 34.24 (-0.67)

Exact Sciences to participate in J.P. Morgan Healthcare Conference
Business Wire - 2 hrs 28 mins ago
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco.
JPM: 58.98 (-1.57), EXAS: 25.94 (-0.68)

Salesforce Executives to Participate in Upcoming Investor Events
PR Newswire - 2 hrs 28 mins ago
Salesforce (NYSE: CRM), the Customer Success Platform and world's #1 CRM company, today announced that Salesforce executives will participate in the following investor events:
JPM: 58.98 (-1.57), CRM: 57.20 (-0.97)

Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - 2 hrs 28 mins ago
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2015 at 4:00 p.m. PT / 7:00 p.m. ET. Dr. Helen Torley, President and Chief Executive Officer, will provide a corporate overview.
HALO: 10.06 (+0.07), JPM: 58.98 (-1.57)

HMS Holdings Corp. to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - 2 hrs 43 mins ago
HMS Holdings Corp. (NASDAQ:HMSY) today announced that Bill Lucia, CEO, will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference at 3:00pm PT / 6:00pm ET on January 14, 2015 at the Westin St. Francis Hotel in San Francisco. A link to the audiocast and supporting materials will be available on the Company's website at http://investor.hms.com/events.cfm.
JPM: 58.98 (-1.57), HMSY: 20.76 (-0.17)

Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results
Business Wire - 2 hrs 57 mins ago
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 12:30 p.m. ET (9:30 a.m. PT). The audio portion of management's remarks may be accessed live through Vertex's website at www.vrtx.com in the "Investors" section under the "Events and Presentations" page.
VRTX: 117.36 (-3.67), JPM: 58.98 (-1.57)

OvaScience Announces Proposed Public Offering of Common Stock
Business Wire - 2 hrs 57 mins ago
OvaScience(SM) (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today it has commenced an underwritten public offering of up to $85 million of shares of its common stock. OvaScience intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of the common stock offered in the public offering. All of the shares in the offering will be sold by OvaScience.
OVAS: 47.18 (-0.08), JPM: 58.98 (-1.57)

Hologic to Present at the 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - 2 hrs 57 mins ago
Hologic, Inc. (NASDAQ: HOLX) announced today that the Company will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2015 at 11:30 a.m. Pacific Time.
JPM: 58.98 (-1.57), HOLX: 25.74 (-0.38)

Portola Pharmaceuticals Announces Webcast of Corporate Presentation on January 12, 2015
GlobeNewswire - 2 hrs 58 mins ago
Portola Pharmaceuticals (Nasdaq TLA) today announced that it will host an investor webcast on Monday, January 12, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time), which will coincide with the 33 Annual J.P. Morgan Healthcare Conference in San Francisco. During the event, Portola's senior management team will provide an update on the Company's recent business progress.
PTLA: 27.06 (-0.76), JPM: 58.98 (-1.57)

Alkermes' Corporate Presentation to be Webcast at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - 2 hrs 58 mins ago
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2015, at 7:30 a.m. PST (10:30 a.m. EST/3:30 p.m. GMT) from the Westin St. Francis Hotel in San Francisco. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
JPM: 58.98 (-1.57), ALKS: 60.93 (+1.55)

Waters Corporation Presentation at the 33rd Annual J.P. Morgan Healthcare Conference to Be Webcast Live
Business Wire - Tue Jan 06, 2:54PM CST
Waters Corporation (NYSE:WAT) Douglas A. Berthiaume, Chairman, President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 12, 2015, at 3:30 p.m. Pacific Time.
JPM: 58.98 (-1.57), WAT: 112.53 (-0.49)

Molina Healthcare to Present at 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Tue Jan 06, 1:00PM CST
Molina Healthcare, Inc. (NYSE: MOH) today announced that management will give a presentation, followed by a question and answer session, at the 33rd Annual J.P. Morgan Healthcare Conference to be held January 12 - 15, 2015, in San Francisco, California.
JPM: 58.98 (-1.57), MOH: 50.36 (-1.07)

LifePoint Hospitals to Participate in 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Tue Jan 06, 12:30PM CST
LifePoint Hospitals, Inc. (NASDAQ: LPNT) today announced that its management will participate in the 33rd Annual J.P. Morgan Healthcare Conference to be held January 12 - 15, 2015, in San Francisco, California.
LPNT: 69.55 (-0.64), JPM: 58.98 (-1.57)

Accolade to Present at the 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Jan 06, 12:30PM CST
Accolade, Inc., today announced that Tom Spann, Chief Executive Officer, will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at the Westin St. Francis Hotel in San Francisco.
JPM: 58.98 (-1.57)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 3

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 0

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 2

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 0

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 1

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 3

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Updated Category News Views 3

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading

Top 5 Most Recently Viewed Articles

Neumora Therapeutics: Upcoming Financial Results and Insights

Updated Category News Views 123

Neumora Therapeutics to Announce Financial Results Neumora Therapeutics, Inc. (Nasdaq: NMRA), a pioneering biopharmaceutical firm, is gearing up to share its financial outcomes for the second quarter of a future year. The conference call is set for 4:30 p.m. ET on a Wednesday, and this event aims to deliver important updates regarding their business and strategic...

Continue Reading
Exciting Insights into Claudin 6 Targeted Therapy for Cancer

Updated Category News Views 165

Introduction to TORL BioTherapeutics and TORL-1-23 TORL BioTherapeutics, LLC is leading the way in developing innovative cancer treatments, particularly focusing on antibody-drug conjugates that target Claudin 6. Their flagship product, TORL-1-23, has shown significant potential in recent clinical trials specifically aimed at patients with Claudin 6 positive cancers. This...

Continue Reading
Understanding Plasma Biomarkers for Liver Health in Youth

Updated Category News Views 118

Plasma Biomarkers and Liver Health in Adolescents Recent research has unveiled an exciting advancement in pediatric medicine regarding liver health in adolescents, particularly among Latino youth facing obesity. The study, conducted by the Children's Hospital Los Angeles, led by Principal Investigator Michael Goran, PhD, has explored the potential of plasma-based...

Continue Reading
Gruma's Market Control: A Look at Price Fixing in Mexico

Updated Category News Views 119

Cofece Ruling on Gruma's Price Fixing Authority In a significant decision that has set the stage for future pricing strategies, Mexico's antitrust authority, Cofece, announced that Gruma, a prominent player in the corn flour and tortilla market, has the ability to fix prices. This conclusion was reached following a comprehensive investigation, which revealed a lack of...

Continue Reading
Coloplast A/S Unveils Strong Financial Performance for 2024/25

Updated Category News Views 190

Coloplast A/S Interim Financial Highlights for 2024/25 Coloplast A/S has recently announced its interim financial results for the period from 1 October 2024 to 30 June 2025. This report unveils the company's impressive organic growth and highlights its strategies for maintaining its market position. Remarkable Growth Figures The latest results showcase an organic growth...

Continue Reading